Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies

Overview of attention for article published in British Journal of Cancer, May 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,939 followers.

https://t.co/v2NcyriB5w Phase I dose-escalation studies of roniciclib, a pan-c... https://t.co/nJQuyE8HgQ via @leroybiotech1 #medical #vets

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.